国泰中证沪港深创新药产业ETF发起联接A(014117)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/3/31 |
28,311,300 |
34,588,500 |
9,615,410 |
3,338,240 |
6,277,170 |
22.17% |
2023/12/31 |
13,816,100 |
28,311,300 |
20,659,500 |
6,164,320 |
14,495,180 |
104.92% |
2023/12/31 |
23,613,200 |
28,311,300 |
6,547,860 |
1,849,800 |
4,698,060 |
19.9% |
2023/9/30 |
20,458,400 |
23,613,200 |
4,682,750 |
1,527,970 |
3,154,780 |
15.42% |
2023/6/30 |
13,816,100 |
20,458,400 |
9,428,910 |
2,786,550 |
6,642,360 |
48.08% |
2023/6/30 |
14,268,900 |
20,458,400 |
7,162,290 |
972,698 |
6,189,592 |
43.38% |
2023/3/31 |
13,816,100 |
14,268,900 |
2,266,620 |
1,813,850 |
452,770 |
3.28% |
2022/12/31 |
10,812,600 |
13,816,100 |
7,003,990 |
4,000,510 |
3,003,480 |
27.78% |
2022/12/31 |
13,156,100 |
13,816,100 |
2,199,560 |
1,539,620 |
659,940 |
5.02% |
2022/9/30 |
12,181,300 |
13,156,100 |
2,095,710 |
1,120,850 |
974,860 |
8% |
2022/6/30 |
10,812,600 |
12,181,300 |
2,708,720 |
1,340,040 |
1,368,680 |
12.66% |
2022/6/30 |
12,161,800 |
12,181,300 |
996,638 |
977,153 |
19,485 |
0.16% |
2022/3/31 |
10,812,600 |
12,161,800 |
1,712,080 |
362,886 |
1,349,194 |
12.48% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。